Risk analysis

Aseptic process

We help and coordinate your team to carry out risk analysis of the processes with a structured, practical approach based on the principles of the ICH Q9 guide on Quality Risk Management. We apply recognized methodologies to identify, assess, and control risks that may affect product quality throughout its lifecycle, with the ultimate goal of protecting the patient and ensuring regulatory compliance.

Our services include:

  • Identification of risks and assessment of the impact on quality.
  • Estimation of the probability, severity and detectability of the risk.
  • Prioritization of risks and establishment of control or mitigation measures.
  • Documentation and communication of results in a clear, auditable way and aligned with regulatory expectations.

We have experience in the application of different risk analysis methodologies, adapted to the characteristics of the process or facility:

  • FMEA (Failure Mode and Effects Analysis): We identify potential failure modes, their causes and effects, and propose preventive or corrective actions.
  • FMECA (Failure Mode, Effects and Criticality Analysis): we extend the FMEA by incorporating criticality analysis to prioritize risks according to their severity, probability and detection capacity.
  • FTA (Fault Tree Analysis): useful for deviation investigations and root cause analysis, visually representing fault chains.
  • HAZOP and HACCP – applicable to complex production processes or critical areas such as aseptic manufacturing.

All of these methods can be combined or adapted depending on the complexity of the process, the level of criticality, and the resources available.

Our approach is based on applying the most appropriate tool to each situation, ensuring that the analysis is not only rigorous and in line with regulatory expectations, but also useful and practical in daily operations.

The ultimate goal is for the decisions derived from the risk analysis to be solid, justified and aligned with the operational reality of your organization.

The analyses are carried out in collaborative and multidisciplinary sessions with your team, facilitating the transfer of knowledge and commitment to the implementation of measures. In addition, we offer support in the integration of risk analysis within your quality system, including linkage with change control, validations, deviation management, and audit preparation.

Well-thought-out risk management not only improves product quality and safety, but can also optimize the use of resources, improve decision-making, and reduce the impact of potential deviations or non-conformities.

Let's control your risks!

Frequently Asked Questions (FAQ)

What is a risk analysis according to the ICH Q9 guideline and why is it essential in the pharmaceutical industry?
Risk analysis, according to the ICH Q9 guide on Quality Risk Management, is a systematic approach to identifying, assessing and controlling risks that may affect product quality during its life cycle. It is essential for complying with GMP regulations, making informed decisions and protecting patient health, as it allows you to anticipate potential problems and establish effective preventive measures.
What risk analysis methodologies do you apply and how do you choose the most appropriate one?
We apply recognized methodologies such as FMEA, FMECA, FTA, HAZOP and HACCP, selecting the most appropriate one based on the complexity of the process, the type of product and the objective of the analysis. Each tool has a specific focus: for example, FMEA is ideal for identifying potential failure modes, while FTA is employed for investigations of deviations or root causes.
What are the benefits of hiring an external consultancy to carry out the risk analysis?
A specialized consultancy provides objectivity, experience and structured methodology, ensuring that the analysis is rigorous, correctly documented and aligned with the expectations of the health authorities. In addition, it facilitates the participation of the internal team in collaborative sessions, promoting learning and ensuring a practical implementation of the proposed measures.
What results are obtained after carrying out a risk analysis with a consultancy?
The result is a clear and structured report that includes risk identification, prioritization, proposed mitigation measures, and monitoring plans.
To which areas or processes can risk analysis be applied in the pharmaceutical industry?
Risk analysis can be applied to a wide variety of processes, operations, and areas, such as sterile production, quality control, validations, change management, storage, product transportation, and critical processes in pharmaceutical facilities. We adapt the methodology according to scope, ensuring a practical and results-oriented approach.